| Bioactivity | LDN-193665 is a Tau kinase inhibitor with tauopathy-modifying activity. LDN-193665 inhibits Tau phosphorylation, improves tauopathy in animal models, reduces Sarkosyl-insoluble Tau, and restores memory. It may be necessary to simultaneously target multiple kinases to effectively inhibit tauopathies. |
| CAS | 1289638-16-9 |
| Formula | C15H11FN4OS |
| Molar Mass | 314.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Diaminothiazoles modify Tau phosphorylation and improve the tauopathy in mouse models |
LDN-193665
CAS: 1289638-16-9 F: C15H11FN4OS W: 314.34
LDN-193665 is a Tau kinase inhibitor with tauopathy-modifying activity. LDN-193665 inhibits Tau phosphorylation, improve
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.